Try our Advanced Search for more refined results
February 01, 2013
Purdue Pharma L.P. et al v. IMPAX Laboratories, Inc.
Case Number:
1:13-cv-00763
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 06, 2013
Purdue, Impax Settle IP Claims In OxyContin Antitrust MDL
Impax Laboratories Inc. has settled a suit alleging its proposed generic version of OxyContin infringed Purdue Pharma LP's patents for a tamper-resistant version of the painkiller, according to a consent judgment filed Friday in a suit that had been rolled into antitrust multidistrict litigation in New York federal court.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login